|
Volumn 70, Issue 5, 2001, Pages 591-601
|
Low density lipoprotein as a targeted carrier for doxorubicin in nude mice bearing human hepatoma HepG2 cells
|
Author keywords
Doxorubicin; Hepatoma; HepG2 cells; LDL
|
Indexed keywords
ANTIBIOTIC AGENT;
DOXORUBICIN;
DOXORUBICIN LOW DENSITY LIPOPROTEIN CONJUGATE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CARDIOTOXICITY;
CELL LEVEL;
CELL LINE;
CELL VACUOLE;
CONTROLLED STUDY;
DRUG ACCUMULATION;
DRUG EFFECT;
DRUG UPTAKE;
ENZYME ACTIVITY;
ENZYME ANALYSIS;
FEMALE;
HEART;
HEART INJURY;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
LIVER;
NONHUMAN;
TREATMENT OUTCOME;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CARCINOMA, HEPATOCELLULAR;
CELL SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOXORUBICIN;
DRUG CARRIERS;
FEMALE;
HEART;
HUMANS;
INJECTIONS, INTRAVENOUS;
L-LACTATE DEHYDROGENASE;
LIPOPROTEINS, LDL;
LIVER;
MICE;
MICE, INBRED BALB C;
MICE, NUDE;
MYOCARDIUM;
NEOPLASM TRANSPLANTATION;
NEOPLASMS, EXPERIMENTAL;
TUMOR CELLS, CULTURED;
MUS MUSCULUS;
|
EID: 0035930959
PISSN: 00243205
EISSN: None
Source Type: Journal
DOI: 10.1016/S0024-3205(01)01441-2 Document Type: Article |
Times cited : (40)
|
References (21)
|